Loading…

Engineered flavoproteins as bioorthogonal photo-triggers for the activation of metal-based anticancer prodrugs

A multifunctional hybrid constructed for controlling the delivery and activation of Pt anticancer agents in vitro is described herein. We employed consensus tetratricopeptide repeat protein (CTPR) for the covalent co-anchoring of riboflavin (photocatalyst) and a Pt( iv ) prodrug complex. The Pt-load...

Full description

Saved in:
Bibliographic Details
Published in:Chemical communications (Cambridge, England) England), 2023-04, Vol.59 (32), p.4754-4757
Main Authors: Mazzei, Laura F, Gurruchaga-Pereda, Juan, Martínez, Álvaro, Martínez, Javier Calvo, Salassa, Luca, Cortajarena, Aitziber L
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c337t-56bce71ee41c62d41e39f38ec3df42469d689e921932a9e5ce6a12a8d40d55003
cites cdi_FETCH-LOGICAL-c337t-56bce71ee41c62d41e39f38ec3df42469d689e921932a9e5ce6a12a8d40d55003
container_end_page 4757
container_issue 32
container_start_page 4754
container_title Chemical communications (Cambridge, England)
container_volume 59
creator Mazzei, Laura F
Gurruchaga-Pereda, Juan
Martínez, Álvaro
Martínez, Javier Calvo
Salassa, Luca
Cortajarena, Aitziber L
description A multifunctional hybrid constructed for controlling the delivery and activation of Pt anticancer agents in vitro is described herein. We employed consensus tetratricopeptide repeat protein (CTPR) for the covalent co-anchoring of riboflavin (photocatalyst) and a Pt( iv ) prodrug complex. The Pt-loaded flavoprotein induced a 40% reduction in PANC-1 cell viability as a result of the photocatalytic formation of cisplatin. Riboflavin-functionalized repeat proteins enable controlling the photocatalytic activation and delivery of Pt anticancer agents in vitro .
doi_str_mv 10.1039/d2cc06363h
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1039_D2CC06363H</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2802252594</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-56bce71ee41c62d41e39f38ec3df42469d689e921932a9e5ce6a12a8d40d55003</originalsourceid><addsrcrecordid>eNpd0c1LHDEYBvBQLLpue-ldCXiRwth87-Qo220tCF5a6G3IJu_MRmaTNckI_vfGrm7BXBLIjye8eRD6QskVJVx_c8xaorjimw9oRrkSjRTt36OXs9TNggt5gk5zvid1UdkeoxOu9EJoRWcorMLgA0ACh_vRPMZdigV8yNhkvPYxprKJQwxmxLtNLLEpyQ8DpIz7mHDZADa2-EdTfAw49ngLxYzN2uSaZ0Lx1gQLCddUl6Yhf0IfezNm-Py6z9GfH6vfy5vm9u7nr-X1bWM5X5RGqrWFBQUQ1CrmBAWue96C5a4XTCjtVKtBM6o5MxqkBWUoM60TxElJCJ-jy31uffhhgly6rc8WxtEEiFPuWEtY20pFVaUX7-h9nFIdeK-YZFKLqr7ulU0x5wR9t0t-a9JTR0n30kL3nS2X_1q4qfj8NXJab8Ed6Nu3V3C2Bynbw-3_GvkzC5WNcA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2802252594</pqid></control><display><type>article</type><title>Engineered flavoproteins as bioorthogonal photo-triggers for the activation of metal-based anticancer prodrugs</title><source>Royal Society of Chemistry</source><creator>Mazzei, Laura F ; Gurruchaga-Pereda, Juan ; Martínez, Álvaro ; Martínez, Javier Calvo ; Salassa, Luca ; Cortajarena, Aitziber L</creator><creatorcontrib>Mazzei, Laura F ; Gurruchaga-Pereda, Juan ; Martínez, Álvaro ; Martínez, Javier Calvo ; Salassa, Luca ; Cortajarena, Aitziber L</creatorcontrib><description>A multifunctional hybrid constructed for controlling the delivery and activation of Pt anticancer agents in vitro is described herein. We employed consensus tetratricopeptide repeat protein (CTPR) for the covalent co-anchoring of riboflavin (photocatalyst) and a Pt( iv ) prodrug complex. The Pt-loaded flavoprotein induced a 40% reduction in PANC-1 cell viability as a result of the photocatalytic formation of cisplatin. Riboflavin-functionalized repeat proteins enable controlling the photocatalytic activation and delivery of Pt anticancer agents in vitro .</description><identifier>ISSN: 1359-7345</identifier><identifier>EISSN: 1364-548X</identifier><identifier>DOI: 10.1039/d2cc06363h</identifier><identifier>PMID: 36974961</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Anticancer properties ; Antineoplastic Agents - pharmacology ; Cell Line, Tumor ; Cisplatin ; Flavoproteins ; Photocatalysis ; Prodrugs - pharmacology ; Riboflavin ; Riboflavin - pharmacology</subject><ispartof>Chemical communications (Cambridge, England), 2023-04, Vol.59 (32), p.4754-4757</ispartof><rights>Copyright Royal Society of Chemistry 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-56bce71ee41c62d41e39f38ec3df42469d689e921932a9e5ce6a12a8d40d55003</citedby><cites>FETCH-LOGICAL-c337t-56bce71ee41c62d41e39f38ec3df42469d689e921932a9e5ce6a12a8d40d55003</cites><orcidid>0000-0002-8541-0839 ; 0009-0005-6646-7943 ; 0000-0002-0729-3809 ; 0000-0001-9513-0518 ; 0000-0002-2112-9095 ; 0000-0002-5331-114X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36974961$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mazzei, Laura F</creatorcontrib><creatorcontrib>Gurruchaga-Pereda, Juan</creatorcontrib><creatorcontrib>Martínez, Álvaro</creatorcontrib><creatorcontrib>Martínez, Javier Calvo</creatorcontrib><creatorcontrib>Salassa, Luca</creatorcontrib><creatorcontrib>Cortajarena, Aitziber L</creatorcontrib><title>Engineered flavoproteins as bioorthogonal photo-triggers for the activation of metal-based anticancer prodrugs</title><title>Chemical communications (Cambridge, England)</title><addtitle>Chem Commun (Camb)</addtitle><description>A multifunctional hybrid constructed for controlling the delivery and activation of Pt anticancer agents in vitro is described herein. We employed consensus tetratricopeptide repeat protein (CTPR) for the covalent co-anchoring of riboflavin (photocatalyst) and a Pt( iv ) prodrug complex. The Pt-loaded flavoprotein induced a 40% reduction in PANC-1 cell viability as a result of the photocatalytic formation of cisplatin. Riboflavin-functionalized repeat proteins enable controlling the photocatalytic activation and delivery of Pt anticancer agents in vitro .</description><subject>Anticancer properties</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Cell Line, Tumor</subject><subject>Cisplatin</subject><subject>Flavoproteins</subject><subject>Photocatalysis</subject><subject>Prodrugs - pharmacology</subject><subject>Riboflavin</subject><subject>Riboflavin - pharmacology</subject><issn>1359-7345</issn><issn>1364-548X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpd0c1LHDEYBvBQLLpue-ldCXiRwth87-Qo220tCF5a6G3IJu_MRmaTNckI_vfGrm7BXBLIjye8eRD6QskVJVx_c8xaorjimw9oRrkSjRTt36OXs9TNggt5gk5zvid1UdkeoxOu9EJoRWcorMLgA0ACh_vRPMZdigV8yNhkvPYxprKJQwxmxLtNLLEpyQ8DpIz7mHDZADa2-EdTfAw49ngLxYzN2uSaZ0Lx1gQLCddUl6Yhf0IfezNm-Py6z9GfH6vfy5vm9u7nr-X1bWM5X5RGqrWFBQUQ1CrmBAWue96C5a4XTCjtVKtBM6o5MxqkBWUoM60TxElJCJ-jy31uffhhgly6rc8WxtEEiFPuWEtY20pFVaUX7-h9nFIdeK-YZFKLqr7ulU0x5wR9t0t-a9JTR0n30kL3nS2X_1q4qfj8NXJab8Ed6Nu3V3C2Bynbw-3_GvkzC5WNcA</recordid><startdate>20230418</startdate><enddate>20230418</enddate><creator>Mazzei, Laura F</creator><creator>Gurruchaga-Pereda, Juan</creator><creator>Martínez, Álvaro</creator><creator>Martínez, Javier Calvo</creator><creator>Salassa, Luca</creator><creator>Cortajarena, Aitziber L</creator><general>Royal Society of Chemistry</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8541-0839</orcidid><orcidid>https://orcid.org/0009-0005-6646-7943</orcidid><orcidid>https://orcid.org/0000-0002-0729-3809</orcidid><orcidid>https://orcid.org/0000-0001-9513-0518</orcidid><orcidid>https://orcid.org/0000-0002-2112-9095</orcidid><orcidid>https://orcid.org/0000-0002-5331-114X</orcidid></search><sort><creationdate>20230418</creationdate><title>Engineered flavoproteins as bioorthogonal photo-triggers for the activation of metal-based anticancer prodrugs</title><author>Mazzei, Laura F ; Gurruchaga-Pereda, Juan ; Martínez, Álvaro ; Martínez, Javier Calvo ; Salassa, Luca ; Cortajarena, Aitziber L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-56bce71ee41c62d41e39f38ec3df42469d689e921932a9e5ce6a12a8d40d55003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Anticancer properties</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Cell Line, Tumor</topic><topic>Cisplatin</topic><topic>Flavoproteins</topic><topic>Photocatalysis</topic><topic>Prodrugs - pharmacology</topic><topic>Riboflavin</topic><topic>Riboflavin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mazzei, Laura F</creatorcontrib><creatorcontrib>Gurruchaga-Pereda, Juan</creatorcontrib><creatorcontrib>Martínez, Álvaro</creatorcontrib><creatorcontrib>Martínez, Javier Calvo</creatorcontrib><creatorcontrib>Salassa, Luca</creatorcontrib><creatorcontrib>Cortajarena, Aitziber L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>MEDLINE - Academic</collection><jtitle>Chemical communications (Cambridge, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mazzei, Laura F</au><au>Gurruchaga-Pereda, Juan</au><au>Martínez, Álvaro</au><au>Martínez, Javier Calvo</au><au>Salassa, Luca</au><au>Cortajarena, Aitziber L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Engineered flavoproteins as bioorthogonal photo-triggers for the activation of metal-based anticancer prodrugs</atitle><jtitle>Chemical communications (Cambridge, England)</jtitle><addtitle>Chem Commun (Camb)</addtitle><date>2023-04-18</date><risdate>2023</risdate><volume>59</volume><issue>32</issue><spage>4754</spage><epage>4757</epage><pages>4754-4757</pages><issn>1359-7345</issn><eissn>1364-548X</eissn><abstract>A multifunctional hybrid constructed for controlling the delivery and activation of Pt anticancer agents in vitro is described herein. We employed consensus tetratricopeptide repeat protein (CTPR) for the covalent co-anchoring of riboflavin (photocatalyst) and a Pt( iv ) prodrug complex. The Pt-loaded flavoprotein induced a 40% reduction in PANC-1 cell viability as a result of the photocatalytic formation of cisplatin. Riboflavin-functionalized repeat proteins enable controlling the photocatalytic activation and delivery of Pt anticancer agents in vitro .</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>36974961</pmid><doi>10.1039/d2cc06363h</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-8541-0839</orcidid><orcidid>https://orcid.org/0009-0005-6646-7943</orcidid><orcidid>https://orcid.org/0000-0002-0729-3809</orcidid><orcidid>https://orcid.org/0000-0001-9513-0518</orcidid><orcidid>https://orcid.org/0000-0002-2112-9095</orcidid><orcidid>https://orcid.org/0000-0002-5331-114X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1359-7345
ispartof Chemical communications (Cambridge, England), 2023-04, Vol.59 (32), p.4754-4757
issn 1359-7345
1364-548X
language eng
recordid cdi_crossref_primary_10_1039_D2CC06363H
source Royal Society of Chemistry
subjects Anticancer properties
Antineoplastic Agents - pharmacology
Cell Line, Tumor
Cisplatin
Flavoproteins
Photocatalysis
Prodrugs - pharmacology
Riboflavin
Riboflavin - pharmacology
title Engineered flavoproteins as bioorthogonal photo-triggers for the activation of metal-based anticancer prodrugs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A36%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Engineered%20flavoproteins%20as%20bioorthogonal%20photo-triggers%20for%20the%20activation%20of%20metal-based%20anticancer%20prodrugs&rft.jtitle=Chemical%20communications%20(Cambridge,%20England)&rft.au=Mazzei,%20Laura%20F&rft.date=2023-04-18&rft.volume=59&rft.issue=32&rft.spage=4754&rft.epage=4757&rft.pages=4754-4757&rft.issn=1359-7345&rft.eissn=1364-548X&rft_id=info:doi/10.1039/d2cc06363h&rft_dat=%3Cproquest_cross%3E2802252594%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c337t-56bce71ee41c62d41e39f38ec3df42469d689e921932a9e5ce6a12a8d40d55003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2802252594&rft_id=info:pmid/36974961&rfr_iscdi=true